ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000905.1|Heme_1 # 2 # 574 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.449	BGC0000905.1|Heme_1 	2	574	+	Loose	450	25.7942	tsnR	62.5	3003060	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (A1067)	AAGCAGATCGACCGGATAAAGATTCATCTGAAGCAAGTGGATCTAGCTGTTTTAGCATTTAAAGGGGCTATCGATGAAAACGTTTACTTTCGTTCACTCGCTCAAGATGCTGCTGTGAGTCAGGAATTGTACCATTTTTTGGTCAATCAAGCTGTTCGTCCGTTTCTCGTCGCTTTTGCCCGGGAATATGCTTCTCGTCTAGACTTGACCCATTGGCAAAGGCCCTATTGTCCGATCTGTGGTCGCTTTTCCGACTTATCACGATTGTCTGGGGACGAAGAGGGCCGCCATCTCGTTTGTATTCATTGCCAGAGTATGTGGGAATATGAGCGCTTGGCTTGTCCCCACTGTGGAAATAAGGAACCAGAAAAATTAGATTATCTATCGACCGAAGAGTACCCAGGATGGCAGATACATATTTGCCAACGATGCCAGGGATACGTTAAGACTGTTGATAGTCGTCAAGCTTTTATCAACCTTTCCGTTCTTGATGAGTTTGATACGCTCATGCTGGACATAATCGCGCGAAAAAAGGGCTATCTTAATGAAAGAATCGGGCCTATTCTTAACTAG	KQIDRIKIHLKQVDLAVLAFKGAIDENVYFRSLAQDAAVSQELYHFLVNQAVRPFLVAFAREYASRLDLTHWQRPYCPICGRFSDLSRLSGDEEGRHLVCIHCQSMWEYERLACPHCGNKEPEKLDYLSTEEYPGWQIHICQRCQGYVKTVDSRQAFINLSVLDEFDTLMLDIIARKKGYLNERIGPILN	MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVPFPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDEALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPMNPAAESLNVSVSAGIALHRRARRNLSRPRG	70.37	gnl|BL_ORD_ID|148|hsp_num:0	49			303	351	thiostrepton
BGC0000905.1|Heme_2 # 595 # 828 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.470	BGC0000905.1|Heme_2 	595	828	+	Loose	2090	21.9422	cmeB	41.67	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTGGTTTTTTGTCTACGATCGGCATACCGGAACTTCTACTTATCCTCGTCGTAGCCCTGTTGATCTTTGGACCTGGAAAGCTTCCAGACGTAGGAAAGGCTCTAGGAAAAAGCATCAATGAATTTAAGAGTGCCACGAGCGCCAGCAAAGCAGAAGAAAAGGTGTCAGAAAAACCAACAGCATCGGGAGACTCCCCAGATCTGGGGAATGCTCCTTCAAAGGACAACTGA	MFGFLSTIGIPELLLILVVALLIFGPGKLPDVGKALGKSINEFKSATSASKAEEKVSEKPTASGDSPDLGNAPSKDN	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	7.40	gnl|BL_ORD_ID|689|hsp_num:0	748			348	420	erythromycin; cefotaxime; fusidic acid
BGC0000905.1|Heme_3 # 926 # 1888 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.493	BGC0000905.1|Heme_3 	926	1888	+	Loose	400	25.7942	EreD	29.79	3004608	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGCAGTCTCGTCTTTTTCAAGATATTCAAAACGACTTGGCCAAAGTGGAAGCCGAACTGGCCAAATATGCCGATACTTCGCTGCCGACGTTGACCGCTGCGTCCAGCCACTTGCTTCATGCAGGAGGAAAACGACTGAGGCCGGCCTTTGTATTGCTGGCTGGCAGGTTTCACAATTACTCTCTTGAGCGCCTATTGCCATTGGCGGTAGCCATGGAGATGATTCACATGGCTTCCTTAGTTCATGACGATGTGGTCGATGAATCGAAGACACGGCGAGGAATCCCAACGGTAAAAGCGCGCTGGGGAAACCGCATTTCAATCCATACAGGCGATCATCTTTTTGCCCGTTCCCTGTTGCTCATCGCCGAACTGAACGATGATAAGATTTCAGAGGTGTTAGCCAAGGTCTCTGTGGAGATGTGTAAAGGTGAGATCCAACAGATGTCTGGCACCTTTGATGTAAACCAAACCTTCCGGGACTATCTGTTCCATATCAAGCGGAAAACAGCTCTTCTCATTTCTGCATCGTGCCAGTTAGGCGCAATGGCAGTTAAAGCCGATCCTTCGATCGTACGGGCGCTGAAAATGTATGGTCATCATCTCGGTATGGCCTTTCAGGTAACCGATGACATTCTCGATTTGACAGCCGACGAAGCAGAACTTGGCAAGCCTGTCGGTTCAGACCTGCGACAGGGCATCATCACTTTACCGATCCTGGAAGCCCTTTGGGAGACGAAAGATCCCCTGTTGCGTCTGTTAGTAGCTAAGCGGGACAAGTCCCAAGAAGAAGTCGGACAAGCGATTGAGATCATAAAAAATTCTGGAGCGATCGATCGCAGCCAAAAAATTGCTCGTCGCTACCTTGAGAAAGCAAAAGACGAGTTAAAGCGCCTGCCGCCGGTGCCAACCCGGGATTCTTTAGCTTCTATTGCCGAATTTATTGAAAAACGAACGTACTAA	MQSRLFQDIQNDLAKVEAELAKYADTSLPTLTAASSHLLHAGGKRLRPAFVLLAGRFHNYSLERLLPLAVAMEMIHMASLVHDDVVDESKTRRGIPTVKARWGNRISIHTGDHLFARSLLLIAELNDDKISEVLAKVSVEMCKGEIQQMSGTFDVNQTFRDYLFHIKRKTALLISASCQLGAMAVKADPSIVRALKMYGHHLGMAFQVTDDILDLTADEAELGKPVGSDLRQGIITLPILEALWETKDPLLRLLVAKRDKSQEEVGQAIEIIKNSGAIDRSQKIARRYLEKAKDELKRLPPVPTRDSLASIAEFIEKRTY	MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLVTECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDNNNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLALNLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFITEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQRLSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKECCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD	78.43	gnl|BL_ORD_ID|1193|hsp_num:0	3305			312	453	erythromycin
BGC0000905.1|Heme_4 # 1967 # 3358 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.480	BGC0000905.1|Heme_4 	1967	3358	+	Loose	400	26.5646	salE	33.33	3007029	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	TTGGTACAATCAAATGCAGACCTTAAGGCTTCAAAGTCTCCAGAAGAACAGTTGAATCAGCAAGATCCCGATAAGGATGGATTTGTCGATAAAGCATGGAACTTTTTTAGTTCTATGAAGCTGGGCCTTTTCCTCTTACTCATCATCGCAGCAGCCTCTATCGCTGGCACCATCATTCCTCAGAACGGTTCCCCTCAAGAATACGGTTCACTTTATTCGCTTTACAACACTTTGGGACTCGTTGACATGTACCACAGTTGGTGGTTTCAAACGCTTTTGTTCCTTCTGGCGATGAATCTGTTTATTTGCTCGGTAAACCGGGCTTCTTCACTATGGCGCGTTTTTTCCAATCCGCGGATTAAAAGGGCTGACGGCGAAATCTCCCGGATGGACCACTCCTTTCATGCTGACAAAGCGATTTCGGAAGAAGGTGTGGTTCAACAGGTAAAGGATGCATGCCGGGATAAGGGTTATCGCGTTTTCACAGAGCAAGAGCCGGGGAGAACATTCCTATATGCCGAAAAGGGGCGTTTTGGCATCTGGGGTTCTCTGATTTCCCATATCGGTTTGCTTGTAATCCTCATCGGTGCTGTCATCGGCATCTATGCCGGCCAAGAAGGCCAGATGCCGGCTGAAGTACACAGCACCTTTCATATCCGAGATGTGCAAGGGCTTGGTACGGTAGACGGAGATTTTGATGTTCGAGTCGATGACTTCAAAACGGTCTATCGTCCCGATGGCTCCATTCAGGCTTGGATCAGTCGTTTGACGATCTTGGACAAAGGTCAAGAAATACTGACTAAGGATATCGAAGTTAACCATCCCCTTGAATTCCGAGGATTTAAGATCTACCAGTCTTTTTATGGCGCGAACATCCCCACGAAAGTCACATCGAAAGAAATCCCGCAAGGTTATGACTTTACGATCAATGAAGGTGACTTCATCCCTGTTCCCGGCACAAATCTGGGTGTCTTGGCCTATAAGTATGTCCCCGATTTTGACCCTCAATATGGCCTCCAGTCGAAGTCTGACCAACCCAACAACCCGCGCATGGTTTACGTGCTATACCGCGGAAAAGAACAGATTGGCGTCGGCGCTGCTGAATTAGGCAAAGCTGAAGTGCTTGCCGGTGGTGAAGGCCAGATCACCTTTCAACGATATGCTCCGTATACAGGGTTGACCATCCGTCGGGATCCCGGAGTGGCTATCGTTTGGTTGGGTTGTGCCGTCCTACTCATCGGTCTGGGATTATCCTTCTACATGCCTCACCGCCGCATCTGGGCCATTGTAGAAGGCAATAACGGAAAGAGCTCGTTATCGTTTGGAGGGTTTGCCCAGAAAAACAAAATCGCCTTTGAACAAGATTTTACTCAATTGAGAGATAAACTCTGA	MVQSNADLKASKSPEEQLNQQDPDKDGFVDKAWNFFSSMKLGLFLLLIIAAASIAGTIIPQNGSPQEYGSLYSLYNTLGLVDMYHSWWFQTLLFLLAMNLFICSVNRASSLWRVFSNPRIKRADGEISRMDHSFHADKAISEEGVVQQVKDACRDKGYRVFTEQEPGRTFLYAEKGRFGIWGSLISHIGLLVILIGAVIGIYAGQEGQMPAEVHSTFHIRDVQGLGTVDGDFDVRVDDFKTVYRPDGSIQAWISRLTILDKGQEILTKDIEVNHPLEFRGFKIYQSFYGANIPTKVTSKEIPQGYDFTINEGDFIPVPGTNLGVLAYKYVPDFDPQYGLQSKSDQPNNPRMVYVLYRGKEQIGVGAAELGKAEVLAGGEGQITFQRYAPYTGLTIRRDPGVAIVWLGCAVLLIGLGLSFYMPHRRIWAIVEGNNGKSSLSFGGFAQKNKIAFEQDFTQLRDKL	MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN	85.27	gnl|BL_ORD_ID|4728|hsp_num:0	5740			3	165	tiamulin; retapamulin
BGC0000905.1|Heme_7 # 4882 # 6189 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.503	BGC0000905.1|Heme_7 	4882	6189	+	Loose	500	26.5646	OXA-29	26.67	3001424	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTTATCTTCGTCGTAGGGCTGAACCATAAATCAGCACCCGTAGAAATTCGAGAACAATTGTCCTTTCCGGAACACATCCTGGAGAGTTCTTTACATCGACTGAAATCGGAACCTGGCATAGAGGGCTGTGCTATTCTATCTACCTGTAACCGTACAGAGATCTACGCGGCGACGACGGATCTGGAAAAAGGTCAAGCTGCTGTGAAGCGATCTTTTCCAACTCGGGCCCCTTGCAGGAAGACGACTTTGCCAATAGCATTTACACTCACACCCTTTATGATGCGATACGTCATCTTTTCCGGGTGTCTGCTGGTCTGGATTTCTATGGTGTTAGGGGAGACGCAGATCCTTGGTCAAGTGCGCCGCGCCTATCAAGCGGCCTGTGACTATGGAACTTCAAACGGGATCATCAACACCTGGTTTCAGCAGGCAATTACTGTAGGCAAACGGGTTCGCACGGAGACGGGTATCGATCAGCATGCTGTTTCTATCTCCTATACGGCGGTGGAATTGGCCCGGCAGGTCTTCGACTCTTTAGAAGGACGAACCGCTTTAATCCTGGGTGCCGGTAAGATGAGCGAACTTACCCTGACTCACCTGATTGCCAACGGGGTGACTACAGTCCTTGTGGCCAACCGTACCCGCGAACGAGCCGATGAACTAGCTCGCAAATGCGGTGGTAAAGCCGTTTCCTTTGCAGAGCTGGAACAACATATGGGAGTCGCAGACATCGTCATCTCTTGTACGGCAGCTACCCACTATGTCATTCGCCGCAATCTCGTAGAGACGGTCATGGCGAAACGGCCAGAACGTCCTCTTTTTCTCATCGATATCGCTGTCCCACGGGATATCGAACCGGCTGTCGGCACGGTACAGTCTGTGCATCTATTCGATATTGACGACCTAAACAGCGTTGTCGACCGGAACTTGGCCGAACGCCAGAAAGCAGCATCCCAGGCGGAAGTCATCATTGAAGAAGAGATCCATGAGTTCATCAAATGGCTCAACTCCTTGTTTGTTGTACCGACGATTGTTGCTTTGCGAAATAAAGGGGACGCGATCAAGGAAAAAGAACTCGAACGGGTGCTGGGAAAGCTGAAAAGCCTTTCCGAAAAGGATAAGAAGACCCTCGGGGCGATGGCCTCTTCCATCGTCAAACAATTGCTGCATGATCCAGTGATTCAAATACGCCATTATGCAGCAAGCCCGGAAGGTCACTTATATTCAGAGATTTTGCAAAATCTCTTTTCCCTAGATATCGCCGGACAGCGGCCGAAAGGCTGTGACGATAACAATCTGAGATAA	MFIFVVGLNHKSAPVEIREQLSFPEHILESSLHRLKSEPGIEGCAILSTCNRTEIYAATTDLEKGQAAVKRSFPTRAPCRKTTLPIAFTLTPFMMRYVIFSGCLLVWISMVLGETQILGQVRRAYQAACDYGTSNGIINTWFQQAITVGKRVRTETGIDQHAVSISYTAVELARQVFDSLEGRTALILGAGKMSELTLTHLIANGVTTVLVANRTRERADELARKCGGKAVSFAELEQHMGVADIVISCTAATHYVIRRNLVETVMAKRPERPLFLIDIAVPRDIEPAVGTVQSVHLFDIDDLNSVVDRNLAERQKAASQAEVIIEEEIHEFIKWLNSLFVVPTIVALRNKGDAIKEKELERVLGKLKSLSEKDKKTLGAMASSIVKQLLHDPVIQIRHYAASPEGHLYSEILQNLFSLDIAGQRPKGCDDNNLR	MKKLSVLLWLTLFYCGTIWAQSTCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGFDSGILKDTLNPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTRFKNYVDAFHYGNQDISGDKGQNNGLTHSWLSSSLAISPSEQIQFLQKIVNKKLSVNPKAFTMTKDILYIQELAGGWKLYGKTGNGRQLTKDKSQKLSLQHGWFIGWIEKDGRVITFTKHIADSKKHVTFASFRAKNETLNQLFYLINELEK	163.53	gnl|BL_ORD_ID|1806|hsp_num:0	1955			264	612	cloxacillin; oxacillin; cefalotin
BGC0000905.1|Heme_8 # 6202 # 7146 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.532	BGC0000905.1|Heme_8 	6202	7146	+	Loose	370	30.0314	bcrB	33.96	3002988	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCAGTACTTCAACGACCAGTTGTCATCGGAACCCGGGACAGTGCTTTGGCGCTCTGGCAGACCAATTGGGTCATGGCCAGATTGAAAGAGTTATTCCCGGAACAAGCTTTCGAGGTTAAAGCGATCAAAACCAAGGGAGACAAAATCCTCGACGTGGCACTGGCCAAAATCGGGGATAAAGGCCTCTTCACGAAAGAACTGGAAGTCTCCATGCTTGAAGGTGAAATCGATATGGCGGTCCACTCATTGAAGGACCTGCCGACGGTTTTGCCGGAAGGTCTAACCATCGGTGCCATGTGTGTCCGTGAAGATTGCCGCGATATTCTCATCTCCCGTCATGGCGGTTTGGATGCACTACCTCAAGGTGCCCGTGTAGGGACAGCCAGTTTGCGGCGAAAAGCCCAGATCTGGCAAGTTCGTCCTGATTTAGAACTTCTGGATATTCGTGGAAACTTGCAAACTCGCCTCCGTAAGATGGAGGAACAAAACCTCGATGGCCTGATTCTCGCTGCTGCTGGAGTGATTCGCCTCGGTTGGGCCGAGAAAATCAGCCAATACATACCGGTAGACATGTGTCTTCCTGCCGTGGGCCAAGGCTCCATCGGCATTGAAATCCGAGAAGGCGATGATGAAATCGCTAAAATCGTCGGCGCTTTGAACCATTATGAGACTTCCGTAAGCATCCGGGCCGAGCGGGCATTGATGCGAACCCTCGAAGGCGGTTGCCAGGTGCCGATTGGCTCGCTGGGACGCCTGCAAGAGGGTCGCCTAGTCCTAGACGGGATCGTAGCATCCCTCGATGGGAAACATGTCGCTCGAGGACGGGAAGAAGGTGACCCGTCACAACCGGAAGAAGTGGGTATCCGTCTGGCCGAACAGCTCTTGCAACAAGGGGCCAGAGAGATATTAAACGTTGTAAGACAGGAGACTGAGTTGCAATGA	MSVLQRPVVIGTRDSALALWQTNWVMARLKELFPEQAFEVKAIKTKGDKILDVALAKIGDKGLFTKELEVSMLEGEIDMAVHSLKDLPTVLPEGLTIGAMCVREDCRDILISRHGGLDALPQGARVGTASLRRKAQIWQVRPDLELLDIRGNLQTRLRKMEEQNLDGLILAAAGVIRLGWAEKISQYIPVDMCLPAVGQGSIGIEIREGDDEIAKIVGALNHYETSVSIRAERALMRTLEGGCQVPIGSLGRLQEGRLVLDGIVASLDGKHVARGREEGDPSQPEEVGIRLAEQLLQQGAREILNVVRQETELQ	MAKKAKYPDVPIRFSETFSDTNLYIVLLIGVPLYGVITSYLFNREYAESTLKNLLTIPVSRISLIVSKLVLLLIWIMMLTLIAWVLTLLFGLIGQFEGLSSAVLIEGFKQFMIGGALLFFLVSPIIFVTLLFKNYVPTIIFTIIISMVSIMVYGTEYSALFPWSAVWVIASGTFFPEYPPEYSFISVAATTVLGLAATIVYFKKIDIH	150.96	gnl|BL_ORD_ID|868|hsp_num:0	944			453	609	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000905.1|Heme_9 # 7143 # 8690 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.543	BGC0000905.1|Heme_9 	7143	8690	+	Loose	200	28.1054	vanH gene in vanO cluster	50.0	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAAACAGAAAGTCGGAAAGGTCTATCTCGTCGGTGCAGGTCCCGGGGATCCCGGACTCATCACTGTAAAAGGTCTGCAGTGTATCCAAAAAGCTGAAGTGCTTGTCTATGACCGTTTGGCTGGTCACCGTTTGCTGACCTACGCCCGTCCTGACGCCGAGTTGATCTTCGTTGGCAAAGGACCGGACAAGCATGTCTATAAACAAGAAGAGATCAACGAAGTCCTTAAGGTCAAAGGTCTGGAAGGCAAAATCGTCACCCGTCTAAAAGGCGGAGATCCCTTCGTCTTCGGCCGTGGCGGTGAAGAAGCTGAAGTTCTGCGGGAAGCTGGCGTTCCTTTTGAGATCGTCCCCGGTATCACCTCAGCCATTTCCGTCCCTGCCTATGCAGGGATCCCTGTGACCCACCGCGATTTTACATCGAACTTCGCCGTGATCACCGGTAATGAAGATCCGAATAAAGAAGACTCGGCCATCGATTGGGCGAAGATCAGCACTGGCATCGGTACTCTGGTCTTCTTGATGGGGATGGGCAACCTGCCGCACATCGCCAGCAAGCTGATGGAACATGGACGCAGCCCTGAAACTCCCGTCGGTCTGATTCGCTGGGGTACACGCCCGGAACAACGGGCGATGACAGGAACCTTGGCCGACATTGCCGACAAAGCCAAAGCGGCTGGATTCCAAAACCCGGCCATCATCATCGTCGGCGAAGTGGTTACCCTCCGGGAAAAACTGGCTTGGTTCGAAGATAAGCCCCTCTTTGGCAAACGCATCGTCGTCACCCGTTCTCGTCAACAAGCGTCGGCCTTTGCCTCCCGCCTCGAAGAGCTGGGAGCAGAGCCTTGGGAGTTTCCCACCATCGATATTCAAGAACCAGCTGACCTGGCTCCTCTGGAAAATGCCATCAGCAAGATTCATGAATACGAGTGGATCATCTTTACATCGCCGAATGGTGTGCAGCGCTTCTTTGAGCGGTTCTTCACCAACGGTCATGACATTCGTGAACTCTTCAACGTCCGCCTCTGCGCCATTGGGCCGCAAACTCGTAAGGAATTGCAGAAGTTCGGCTTGAAAGTCGACTTCGTGCCTGAAGAATATCGTGCGGAAGCCATCGTCGAAGGCCTGAAAAACCTCGATGACTGGAAGGGTCGCAAAGTCCTGCTGCCTCGCGCTGATATCGCCCGTAAGATTCTGCCGGAAGCACTCACCAGCTTTGGTGCTGAAGTCGATGATGTAGTGGCCTACCGGACCGTACGCGGCGGTGGCGACGCGACACTGCTCCGTCAGATGATGGAAGAGAAGATGATCAGTGCCGTAACCTTCACCAGTTCCTCCACAGCTCGTAACTTTGTGGAAATGCTCGGTGTTGATGCTGCAGAACGGGAGCGTCTGCTCGATGGCGTTACCTTGGCATCGATCGGTCCTATCACCTCTGATACGATGAAGGAACTGGGCCTCCGTGTTGATGTGGAAGCCACCGAATACACCATTCCCGGGTTGACCCGTGCCTTGATGGCTCATTGGAACATACAACTTCCCGAGTAA	MKQKVGKVYLVGAGPGDPGLITVKGLQCIQKAEVLVYDRLAGHRLLTYARPDAELIFVGKGPDKHVYKQEEINEVLKVKGLEGKIVTRLKGGDPFVFGRGGEEAEVLREAGVPFEIVPGITSAISVPAYAGIPVTHRDFTSNFAVITGNEDPNKEDSAIDWAKISTGIGTLVFLMGMGNLPHIASKLMEHGRSPETPVGLIRWGTRPEQRAMTGTLADIADKAKAAGFQNPAIIIVGEVVTLREKLAWFEDKPLFGKRIVVTRSRQQASAFASRLEELGAEPWEFPTIDIQEPADLAPLENAISKIHEYEWIIFTSPNGVQRFFERFFTNGHDIRELFNVRLCAIGPQTRKELQKFGLKVDFVPEEYRAEAIVEGLKNLDDWKGRKVLLPRADIARKILPEALTSFGAEVDDVVAYRTVRGGGDATLLRQMMEEKMISAVTFTSSSTARNFVEMLGVDAAERERLLDGVTLASIGPITSDTMKELGLRVDVEATEYTIPGLTRALMAHWNIQLPE	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	147.14	gnl|BL_ORD_ID|761|hsp_num:0	786			108	186	vancomycin
BGC0000905.1|Heme_10 # 8835 # 10010 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.502	BGC0000905.1|Heme_10 	8835	10010	+	Loose	850	27.335	adeC	41.67	3003811	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCGGAGTAAGTAAACTGCTTGTCGGCAGCGAGAACTATGGCGATCGGTTGCGTTACGCCAGCGGATCCCATGGACAGCGGAACGGCGCCGTTGAAGGATATGGCCCTGTCGTCGCTTGGAACGTATCCCGGACCTGTAACCTGCACTGCATTCATTGCTATTCCGACTCCGATGAAATCGATTATCCCGGCGAACTGACAACCCAGGAAGCCATCAAGTTCATCGACGAACTAGCCGATTTCAATGTTCCTGTGTTGCTGCTTTCCGGTGGCGAACCGTTGATGCGTCCCGACATTTTTGAACTCGTCGCTCATGCCAGCAAGCGGAACGTCCGGGTTACCTTCTCTACAAACGGAACCTTGATCACCCCCGATGTAGCCAAAGAAATTAAAAAATATGGCGTCGGATACGTAGGCATCAGCCTTGACGGTATCGGCGAAAACAACGATAAATTCCGCGGTAAAAAAGGCGCTTTCGAAGAAGCCTTAAACGGTATTCGCAACTGTCTGGCTATCGACCAACGGGTCGGCCTGCGCTTCACCATCAACAAGCATAACTTTAATGACCTGGAAAACATCTTCAATCTGATTGAAGAAGAAAAGATTCCCCGCGTTTGCTTCTATCACCTCGTTTACTCCGGTCGAGGCGGCAGCATGATGGAAGAAGATATGACCCGTCAAGAAGCTCGTGAAGCGATGGACCTGATCATGGCCAAATCAGTGGAATTCCACAAAAAAGGTTTTGATTGTGAAATCCTCACCGTCGACAACCATGCCGACATTGTCTACCTGTACCTGAAGATGAAAGATAAAGATCCCGTTCTAGCTGAAAAAATCTGGAAGCTGATGCAACTGAACGGCGGCAACCGCTCCGGTATCGCCTTTGCCAACGTTGACTCCCAAGGATTTGTTCACCCTGACCAATTCACTCAAAACCATACCTTTGGCAACGTCAAAGAACGTCCCTTCAAAGAGATCTGGTCTGACACTTCCAGCAACCCCATCTTGGCTGGTCTGAAAGATCGGAAGCCCTTGCTCAAAGGACGCTGTGCCAAGTGTAAATGGCTCAACGTTTGCAACGGTAACTTCCGTGCCCGTGCAGAAGCCGTAACCGGCGATTTCTGGGAGTCTGATCCGGCTTGCTACCTCACCGATGAGGAAATCGGCCTGTAA	MIGVSKLLVGSENYGDRLRYASGSHGQRNGAVEGYGPVVAWNVSRTCNLHCIHCYSDSDEIDYPGELTTQEAIKFIDELADFNVPVLLLSGGEPLMRPDIFELVAHASKRNVRVTFSTNGTLITPDVAKEIKKYGVGYVGISLDGIGENNDKFRGKKGAFEEALNGIRNCLAIDQRVGLRFTINKHNFNDLENIFNLIEEEKIPRVCFYHLVYSGRGGSMMEEDMTRQEAREAMDLIMAKSVEFHKKGFDCEILTVDNHADIVYLYLKMKDKDPVLAEKIWKLMQLNGGNRSGIAFANVDSQGFVHPDQFTQNHTFGNVKERPFKEIWSDTSSNPILAGLKDRKPLLKGRCAKCKWLNVCNGNFRARAEAVTGDFWESDPACYLTDEEIGL	MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV	84.09	gnl|BL_ORD_ID|307|hsp_num:0	337			111	183	tigecycline; tetracycline
BGC0000905.1|Heme_13 # 12373 # 12858 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.500	BGC0000905.1|Heme_13 	12373	12858	+	Loose	500	26.9498	GOB-29	23.64	3005678	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGAGTCTCGATGATCTGGACCGTCGATTGTTGACCATTATCCAGTCATCTTTCCCCATTGCCGCCGAACCTTACAAACAACTGGCTGAAGAATTGAATACCACAGAAGAGGACATCCTCTCCCGGGTTCAACGCTTCAAAGATACAGGCCTCATTCGGCGCATTGGCGGCATCTTCGATTCCCGCAACTTGGGCTACAAGTCGACCTTGTGCGCTATGAGAGCACCTGAGGATAAGTTAGAAAAGGCGATCGCCGTCGTCAACGAATACCCGGGTGTGACTCATAACTACCTGCGGGAACACGAATTTAATGTTTGGTTTACCCTGATCACACCTTCGGAAGAATATATGGAGAAGGTGCTCGATGAGATCCGAGAGCGGACTGGCTGTGAAGTACATAACCTGCCGGCAGTTCGTTTCTTCAAGATTAAAGTCGATTTCAGATTGGACAAGGAACGGCAAGGGGCCGCCGAAGCGGCGCAATAA	MSLDDLDRRLLTIIQSSFPIAAEPYKQLAEELNTTEEDILSRVQRFKDTGLIRRIGGIFDSRNLGYKSTLCAMRAPEDKLEKAIAVVNEYPGVTHNYLREHEFNVWFTLITPSEEYMEKVLDEIRERTGCEVHNLPAVRFFKIKVDFRLDKERQGAAEAAQ	MRNFVTLFFLLVCLSLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESFPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKFYADKADADVLRTGGKSDYELGKYGVTFKPVTPDKTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKILIANMPSIIVDKKFSEVTAYPGIQSDYAYTFKAMKNLDFDVWVASHASQFDLHTKRKEGDSYNPQLFMDKKNYFKRLERLENNYFEKIKEDSKDK	55.52	gnl|BL_ORD_ID|3573|hsp_num:0	4642			546	711	
BGC0000905.1|Heme_16 # 14871 # 15719 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.477	BGC0000905.1|Heme_16 	14871	15719	+	Loose	500	26.9498	RSA-2	27.63	3004445	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	RSA beta-lactamase	ATGTGGTTGGTCTTAGCTCTATCGAGCGCTGTCGTTTTTGGTTTAGCTGGTTTTGGCATGAAAGTGGGGCAAATGCGAGGGGTCCCATCGTCTTTGGTGCTCATCGGTCTATATTTATCGGGTACACTGGGATTCCTAATAACGTGGTCGATGGCCGGAGCTGTCACCTCATGGCCTGTCATTTTAGCAGGCTTGATCATCGGTATTGGCTCTGCCGGAGGAAATTATGTCTTTATGAAGGCTATCGAAAGCGGGCCGGCTAGTTTGACTTCACCGATCATCAACATGAACGTAGTGCTCGTGATCGGCTTGTCAGTCTTGATCTATGGTGAGACCATGAACCTGACGAAGACAATCGGTGTCACCTTATTTCTAATCGCCATCATCTTAATCGCGATTAAACCGGATAAGAGCAAAGGGATGAACACTTCGGCTTTCTGGTTAAGTATGGTGATGCTGAGTACCTTGCTTTTCGCTGTTCGCAACGGTGGACTCAAAGTCACTCAAGAACTGGCTATGGATAACAGCGCCGTACTCTTTTTTAGCTACCTCATACCGACGATCTTTTTTTTAGTACGGTATCGGGCGGAACTGATGGAACTGAAAGCGGGTGAAATCCTTCCTCAGTTGGGTTGGGGCTTAGTGAGCGGGCTAGGTTCTTTCGGAGGAATGCAACTTTATGCCTATGCCTTATCTCAAGGACCGGCTTCGATTATATCGCCTGTTTTTTCTCTATACGGACTGGTGATTGTTCTATTATCGGTTGGCGTCTATAAAGAACGCCTCACCGCCTTGCAGACTTTGGCGGTAGCTCTTACCTTTGTGGGTCTCATCCTGGTCAAGTCTTGA	MWLVLALSSAVVFGLAGFGMKVGQMRGVPSSLVLIGLYLSGTLGFLITWSMAGAVTSWPVILAGLIIGIGSAGGNYVFMKAIESGPASLTSPIINMNVVLVIGLSVLIYGETMNLTKTIGVTLFLIAIILIAIKPDKSKGMNTSAFWLSMVMLSTLLFAVRNGGLKVTQELAMDNSAVLFFSYLIPTIFFLVRYRAELMELKAGEILPQLGWGLVSGLGSFGGMQLYAYALSQGPASIISPVFSLYGLVIVLLSVGVYKERLTALQTLAVALTFVGLILVKS	MIKKIISGACLVLLAGCVLGVKPAGKETGFMIDSGRFAGMDGCAIVFDARMGKIAGVYGEKRCKERVTACSTFKVPLALMAFDSGVLSDESTVLKWDGVQWPFDSWNQDQTAASWLRNSVVWYSQRLTPMLGLEKIKAYLKAFDYGNQDFSSGLTSAWLTITKSDTNPDKGSLKISAYEELEFFRRFWRGALPVSGAAVEKTKKMIYLETSPGGYALHGKTGSGYLDGLTGDFGWFAGHVEGKGREYFVVTAVTRNGNAADARIPGLVAKELAKNILKDNSVW	99.65	gnl|BL_ORD_ID|2494|hsp_num:0	2885			33	249	
BGC0000905.1|Heme_17 # 15721 # 16359 # -1 # ID=1_17;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.479	BGC0000905.1|Heme_17 	15721	16359	-	Loose	700	29.6462	FOX-4	28.05	3002158	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	ACGGCTCATTGGATTGTCAGCACTTACGGCGACGTAGGCCTTTTTCTGGGCCTTTTTTTCGAGTTTTTGGGAGCTCCCTTTCCCGGAGAGATTTCTCAAGCTTTTGCCGGTTTTCTTATTTCTCAAGATCGCCTACAGCTTCACGTCACTTTACTTAGCTGTGTTGCCGGCAGCCATTTAGGTTCGATGGTCGCCCATGTGATCGGAACCCGTTATGGACAGCTTGTTCTATACAAATGGGCTCCCCGAATGGGATTGAAGCGGGAGTATATTGAAAGGACAGAGTCCTGGTTCCGCCGCAATCGTATTACGATGATCTTCTTTAGTCGCTGGATCATCGGCGTGCGTCATGTGACCCCCTATTTTACCGGTCTCGTTCGCATGGGTTTTTGGGAGGCCTTTTTCTGGAACTTGTTAGGTTCGATTCTTTGGTGTACGCCGATCATCTTTATTGGCATAGCCGCCGGCGAAGCTTATGAAGCGATGATGGGAGAGTTCCATCATTATGTGAACGTCTTAGTTTTCGCCGGCTTTTTAGTTATGGGCACCGCTTATCTGCTATATAGATACCGGAACTCTGCTACGAAAAAGTCTCCTGTGAAAGCGGCTTCAGAAAGAATCAGAGAGAACGAAGAATAG	TAHWIVSTYGDVGLFLGLFFEFLGAPFPGEISQAFAGFLISQDRLQLHVTLLSCVAGSHLGSMVAHVIGTRYGQLVLYKWAPRMGLKREYIERTESWFRRNRITMIFFSRWIIGVRHVTPYFTGLVRMGFWEAFFWNLLGSILWCTPIIFIGIAAGEAYEAMMGEFHHYVNVLVFAGFLVMGTAYLLYRYRNSATKKSPVKAASERIRENEE	MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	55.50	gnl|BL_ORD_ID|1581|hsp_num:0	1726			423	645	
